Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Amortization of Deferred Charges (2018 - 2020)

Dna X filings provide 3 years of Amortization of Deferred Charges readings, the most recent being -$169000.0 for Q4 2020.

  • On a quarterly basis, Amortization of Deferred Charges fell 153.31% to -$169000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $166000.0, a 79.04% decrease, with the full-year FY2020 number at $166000.0, down 54.77% from a year prior.
  • Amortization of Deferred Charges hit -$169000.0 in Q4 2020 for Dna X, down from $169000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $386000.0 in Q3 2018 to a low of -$169000.0 in Q4 2020.
  • Median Amortization of Deferred Charges over the past 3 years was $228000.0 (2018), compared with a mean of $168222.2.
  • Biggest five-year swings in Amortization of Deferred Charges: skyrocketed 256.18% in 2019 and later tumbled 153.31% in 2020.
  • Dna X's Amortization of Deferred Charges stood at $89000.0 in 2018, then skyrocketed by 256.18% to $317000.0 in 2019, then tumbled by 153.31% to -$169000.0 in 2020.
  • The last three reported values for Amortization of Deferred Charges were -$169000.0 (Q4 2020), $169000.0 (Q3 2020), and -$89000.0 (Q2 2020) per Business Quant data.